Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-03-16
4:19 pm
Sale
13DAptinyx Inc.
APTX
Longitude Capital Partners II LLC192,805
0.3%
-3,451,746decrease
(-94.71%)
View
2023-02-14
4:31 pm
Purchase
13DAptinyx Inc.
APTX
Longitude Capital Partners II LLC3,644,551
5.4%
137,807increase
(+3.93%)
View
2023-02-14
4:17 pm
Sale
13GRapid Micro Biosystems, Inc.
RPID
Longitude Capital Partners II LLC4,189,845
11.3%
-2,702decrease
(-0.06%)
View
2023-02-14
4:15 pm
Sale
13DKala Pharmaceuticals, Inc.
KALA
Longitude Capital Partners II LLC108,239
6.3%
-5,348,791decrease
(-98.02%)
View
2023-01-03
5:04 pm
Sale
13DVenus Concept Inc.
VERO
Longitude Capital Partners II LLC3,466,118
5%
-225,231decrease
(-6.10%)
View
2022-02-14
6:38 pm
Purchase
13GRapid Micro Biosystems, Inc.
RPID
Longitude Capital Partners II LLC4,192,547
12.2%
4,192,547increase
(New Position)
View
2021-08-13
5:15 pm
Purchase
13DRxSight, Inc.
RXST
Longitude Capital Partners II LLC2,506,972
9.1%
2,506,972increase
(New Position)
View
2021-02-12
5:12 pm
Purchase
13GVaxcyte, Inc.
PCVX
Longitude Capital Partners II LLC3,108,780
6.1%
3,108,780increase
(New Position)
View
2020-03-23
5:00 pm
Purchase
13DKala Pharmaceuticals, Inc.
KALA
Longitude Capital Partners II LLC5,457,030
10%
2,561,664increase
(+88.47%)
View
2020-02-12
4:34 pm
Purchase
13DAptinyx Inc.
APTX
Longitude Capital Partners II LLC3,506,744
8%
316,665increase
(+9.93%)
View
2020-02-12
4:32 pm
Purchase
13GNabriva Therapeutics plc
NBRV
Longitude Capital Partners II LLC4,256,527
4.5%
244,152increase
(+6.08%)
View
2020-02-12
4:24 pm
Purchase
13GAimmune Therapeutics Inc.
AIMT
Longitude Capital Partners II LLC6,215,278
9.8%
23,750increase
(+0.38%)
View
2019-11-18
4:21 pm
Purchase
13DVenus Concept Inc.
VERO
Longitude Capital Partners II LLC3,691,349
12.4%
3,691,349increase
(New Position)
View
2019-02-12
5:07 pm
Purchase
13GAimmune Therapeutics Inc.
AIMT
Longitude Capital Partners II LLC6,191,528
10%
33,093increase
(+0.54%)
View
2018-10-12
4:19 pm
Purchase
13DKala Pharmaceuticals, Inc.
KALA
Longitude Capital Partners II LLC2,895,366
9%
616,860increase
(+27.07%)
View
2018-08-07
4:51 pm
Purchase
13GNabriva Therapeutics plc
NBRV
Longitude Capital Partners II LLC4,012,375
6%
4,012,375increase
(New Position)
View
2018-07-06
4:15 pm
Purchase
13DTricida Inc.
TCDA
Longitude Capital Partners II LLC3,021,924
7.2%
3,021,924increase
(New Position)
View
2018-07-02
5:26 pm
Purchase
13DAptinyx Inc.
APTX
Longitude Capital Partners II LLC3,190,079
9.5%
3,190,079increase
(New Position)
View